title: Update on new drugs in dermatology.
abstract: Medications in dermatology are used in a variety of different methods and dosages and for numerous different diseases entities that are not approved by the US Food and Drug Administration (FDA); however, there are medications that have only recently hit the market that require our attention, as they are either FDA approved for the intended dermatologic use or could be effective in treating conditions that previously have been poorly managed.
authors.affiliation: Department of Dermatology, University of Florida, Gainesville, USA.
authors.forename: Divya
authors.initials: D
authors.lastname: Shokeen
mesh_terms: D000622:Aminolevulinic Acid / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D001384:Azetidines / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D003357:Cosmetic Techniques; D003840:Deoxycholic Acid / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use*; D017277:Drug Approval; D005148:Facial Dermatoses / Q000188:drug therapy; D006801:Humans; D055623:Keratosis, Actinic / Q000188:drug therapy*; D008545:Melanoma / Q000188:drug therapy*; D050130:Oncolytic Virotherapy / Q000379:methods; D010880:Piperidines / Q000627:therapeutic use; D011565:Psoriasis; D011725:Pyridines / Q000627:therapeutic use; D012536:Scalp Dermatoses / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D001384:Azetidines; D001713:Biphenyl Compounds; D003879:Dermatologic Agents; D010880:Piperidines; D011725:Pyridines; D003840:Deoxycholic Acid; C561435:sonidegib; D000622:Aminolevulinic Acid; C549079:ixekizumab; C555450:secukinumab; C574276:cobimetinib